货号: CL-0585
Price: ¥2500 ¥2500
生长培养基: Ham's F-12K[PM150910]+10% FBS[164210]+1% P/S[PB180120]+1 μg/mL TAX
产品信息
产品名称 | A549-TAX(人肺腺癌紫杉醇耐药性细胞) |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:Ham's F-12K[PM150910]+10% FBS[164210]+1% P/S[PB180120]+1 μg/mL TAX 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:2-1:3 |
推荐换液频率 | 2-3次/周 |
注意事项 |
|
参考资料(来源文献)
背景描述 | A549/Tax细胞是在A549细胞基础上,通过剂量递增法建立的耐紫杉醇药物的细胞株。 |
组织来源 | 未知 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肺癌细胞 |
STR位点信息
STR鉴定图
-
A novel amino-pyrimidine inhibitor suppresses tumor growth via microtubule destabilization and Bmi-1 down-regulation(2025)
作者:Lijie Gao, Jiawei Liu, Rui Zhang, Xi Chen, Mo Wang, Yujia Dong, Mykhaylo S. Frasinyuk, Wen Zhang, David Watt, Wenxiang Meng, Jun Xue, Chunming Liu, Yu Cheng, Xifu Liu
期刊:BIOCHEMICAL PHARMACOLOGY
影响因子:5.3
引用产品: A549/Tax 细胞, Ham's F-12K 培养基
-
Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer(2024)
作者:Xiaojie Yan, Xueying Zhao, Mingde Fan, Wenfu Zheng, Guanxiong Zhu, Bin Li, Le Wang
期刊:International Journal of Nanomedicine
影响因子:8.0
引用产品: A549/Tax 细胞, U251 细胞, 786-O [786-0] 细胞
-
Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy(2024)
作者:Haobing Wang, Yidan Lai, Dan Li, Johannes Karges, Pingyu Zhang, Huaiyi Huang
期刊:JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1021/acs.jmedchem.3c01889
影响因子:7.3
引用产品: A549 [A-549] 细胞, A549/DDP 细胞, A549/Tax 细胞, A-431 细胞, MRC-5 细胞
-
MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis(2024)
作者:Nian Dong, Wen-Wen Gu, Long Yang, Wen-Bo Lian, Juan Jiang, Hai-Jun Zhu, Cheng-Shui Chen, Bei-Bei Wang
期刊:INTERNATIONAL IMMUNOPHARMACOLOGY
DOI:10.1016/j.intimp.2024.112547
影响因子:4.8
引用产品: BEAS-2B 细胞, Ham's F-12K 培养基, A549/Tax 细胞, A549 [A-549] 细胞, NCI-H1975 细胞, BEAS-2B细胞专用培养基
-
Combination of polythyleneimine regulating autophagy prodrug and Mdr1 siRNA for tumor multidrug resistance(2022)
作者:Wang Changduo, Li Zhipeng, Xu Ping, Xu Lisa, Han Shangcong, Sun Yong
期刊:JOURNAL OF NANOBIOTECHNOLOGY
DOI:10.1186/s12951-022-01689-y
影响因子:9.4
引用产品: A549 [A-549] 细胞, A549/Tax 细胞
-
Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation(2021)
作者:Tingting Zou, Cheng Zeng, Junyan Qu
期刊:Biomedicines
DOI:10.3390/biomedicines9091143
影响因子:4.7
引用产品: MCF-7/ADM 细胞, MCF7 [MCF-7] 细胞, A549 [A-549] 细胞, A549/Tax 细胞
-
RNA editing enzyme adenosine deaminases acting on RNA 1 deficiency increases the sensitivity of non-small cell lung cancer cells to anlotinib by regulating CX3CR1-fractalkine expression(2021)
作者:Min Wu, Mengmeng Jin, Xiaohui Cao
期刊:Drug Development Research
影响因子:3.8
-
Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation(2020)
作者:Yanna Zhao, Chang Cai, Min Liu
期刊:International Journal Of Biological Macromolecules
DOI:10.1016/j.ijbiomac.2020.03.060
影响因子:8.2
-
Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel(2020)
作者:Yonghong Wang, Hongli Yu, Saisai Wang
期刊:Materials Science and Engineering: C
DOI:10.1016/j.msec.2020.111442
影响因子:1.9
引用产品: A549 [A-549] 细胞, A549/Tax 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图